Purchases and Sales Made in Q2 2022 in Ambrx Biopharma Inc. (AMAM)
This table provides information about the institutional ownership of Ambrx Biopharma Inc. (AMAM) during Q2 2022. The information is specifically focused on institutions that hold shares of Ambrx Biopharma Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Aug 14, 2023
Q2 2022
|
Norges Bank
Oslo, Q8 |
BUY
|
- |
62.4KNew |
$158K - $271K
|
62.4K
$1.75M
|
|
|
Aug 10, 2022
Q2 2022
|
Ubs Group Ag
|
BUY
|
- |
242New |
$612 - $1.05K
|
242
$6.78K
|
|
|
Aug 09, 2022
Q2 2022
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
Aug 12, 2022
Q2 2022
|
Bank Of America Corp
Charlotte, NC |
SELL
|
- |
-140- 58.09% |
$354 - $609
|
101
$2.83K
|
|
|
Aug 15, 2022
Q2 2022
|
Paul Tudor Jones
Tudor Investment Corp Et Al | Stamford, Ct
|
SELL
|
- |
-1.08K- 5.36% |
$2.73K - $4.7K
|
19.1K
$534K
|
|
|
Aug 15, 2022
Q2 2022
|
Morgan Stanley
New York, NY |
SELL
|
- |
-2.8KClosed |
$7.08K - $12.2K
|
0
$0
|
|
|
Aug 12, 2022
Q2 2022
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
SELL
|
- |
-11.6K- 51.33% |
$29.3K - $50.5K
|
11K
$308K
|
|
|
Aug 15, 2022
Q2 2022
|
Octagon Capital Advisors LP
New York, NY |
SELL
|
- |
-26.6K- 17.8% |
$67.3K - $116K
|
123K
$3.44M
|